Global Collaborative Research Push Resonates Across Airwaves
The launch of the Global Ovarian Cancer Research Consortium has garnered significant media attention, with coverage appearing on NBC News Radio, FOX 5 Washington D.C., KUNS-TV Seattle, WRC-TV Washington D.C. (NBC), WJFF-FM New York (NPR affiliate), and FemTech Insider, among others.
The Consortium’s inaugural initiative is a new AI Accelerator Grant — a game-changing $1 million grant with an additional $1 million in compute support from Microsoft’s AI for Good Lab, which aims to harness the power of artificial intelligence to improve outcomes.
This collaborative effort signifies a hopeful advancement in ovarian cancer research, striving to improve outcomes for patients worldwide.
FDA Gives Its First-Ever Approval of Treatment for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets), making it the first FDA-approved treatment for patients with KRAS-mutated recurrent low-grade serous ovarian cancer. Clinical leadership on the trial that led to this groundbreaking approval comes from Dr. Rachel Grisham, whose earliest work was funded by OCRA.
June is Uterine Cancer Awareness Month
Uterine (or endometrial) cancer is the most common type of gynecologic cancer, with more than 886,000 women living with the disease in the U.S.
OCRA is here for those impacted by uterine cancer and all gynecologic cancers. Learn about our resources and programs for patients, survivors, and loved ones, and find out how you can get involved.
OCRA’s Advocate’s Corner
As Congress ramps up work on the FY26 federal budget, advocates are focused on maintaining vital cancer programs and advancing state policies that support gynecologic cancer patients.
Learn what’s happened over the last month—including some key legislative wins—and find out what’s next, in OCRA’s Advocate’s Corner.
NCCN 2025 Guidelines for Cervical Cancer Patients Now Available, Sponsored by OCRA
OCRA is proud to sponsor National Comprehensive Cancer Network’s 2025 Guidelines for Patients: Cervical Cancer.
View this free resource containing clear and updated information written specifically for cervical cancer patients and caregivers.
Out of Patients Podcast with Audra Moran
In a wide-ranging interview on the podcast Out of Patients with Matthew Zachary, OCRA’s President & CEO Audra Moran discusses OCRA’s programs, the promise of AI, and more.
Listen to the podcast episode “OCRA, Acronyms, and Audra: The Nonprofit Multiverse of Madness.”
New Support & Education Sessions
Book Club: “North Woods,” by Daniel Mason
June 17th at 3pm ET
Register here.
Webinar: Gynecologic Cancer Updates from SGO & ASCO
June 18th at 11am ET
Register here.
Express Yourself: Emotional Lines
June 26th at 3pm ET
Register here.
Support Sessions are generously supported by Merck, Genmab and GSK.
Ways to Give: Promise Circle
When you pledge a monthly gift to OCRA, you become part of The Promise Circle, a truly exceptional group of donors who care so deeply about supporting ovarian and gynecologic cancer research, advocacy, and patient support that they want their funding to be steady and enduring. Become a monthly donor today.
